ID	Database	Citation
37858338	Pubmed	"High-throughput chemogenetic drug screening reveals PKC-RhoA/PKN as a targetable signaling vulnerability in GNAQ-driven uveal melanoma. Arang N, Lubrano S, Ceribelli M, Rigiracciolo DC, Saddawi-Konefka R, Faraji F, et al. Cell Rep Med. 2023 Nov 21;4(11):101244.  <a href=""http://www.ncbi.nlm.nih.gov/pubmed/37858338"" target=""_blank"" class=""external"" rel=""nofollow"">PubMed</a> <a href=""https://europepmc.org/abstract/MED/37858338"" target=""_blank"" class=""external"" rel=""nofollow"">Europe PMC</a> <a href=""https://scholia.toolforge.org/pubmed/37858338"" target=""_blank"" class=""external"" rel=""nofollow"">Scholia</a>"
